CCK-8 Ammonium Attenuates Anxiety in Morphine Withdrawal via
2026-07-24
This study demonstrates that cholecystokinin octapeptide (CCK-8) exerts anxiolytic effects in morphine-withdrawal rats through endogenous opioid pathways, mediated specifically by CCK1 receptor activation. The findings clarify the neuropeptidergic modulation of withdrawal-induced anxiety and identify central CCK1 receptors as promising targets for addiction therapy.
Liproxstatin-1 HCl in Ferroptosis Assays: Protocols & Insigh
2026-07-24
Liproxstatin-1 HCl offers nanomolar potency and unmatched selectivity for dissecting ferroptotic mechanisms in acute renal failure and hepatic ischemia/reperfusion injury models. This guide translates recent mechanistic breakthroughs into actionable workflows, troubleshooting tips, and comparative advantages for ferroptosis research.
GM 6001 (Galardin): Redefining MMP Inhibition in Cancer and
2026-07-23
Discover how GM 6001 (Galardin) is revolutionizing matrix metalloproteinase inhibition beyond traditional ECM and neurobiology research. This article unveils novel applications in cancer, vascular biology, and inflammation, setting a new benchmark for advanced assay design.
Applied (-)-Norepinephrine (+)-bitartrate in Cardiomyopathy
2026-07-23
Harness the versatility of (-)-Norepinephrine (+)-bitartrate for precise adrenergic receptor studies and reliable cardiovascular modeling. Discover workflow-anchored protocols, advanced assay optimizations, and troubleshooting strategies proven to elevate reproducibility in cardiomyopathy and blood pressure research.
NP-Mediated PTEN mRNA Delivery Reverses Trastuzumab Resistan
2026-07-22
This study introduces a nanoparticle platform enabling systemic delivery of PTEN mRNA to overcome trastuzumab resistance in HER2-positive breast cancer models. By restoring PTEN and inhibiting the PI3K/Akt pathway, the approach offers a mechanistically targeted strategy for tackling antibody therapy resistance.
IWP-L6: Precision Porcupine Inhibitor for Wnt Pathway Modula
2026-07-22
IWP-L6 is a sub-nanomolar Porcupine inhibitor that selectively blocks Porcn-mediated Wnt protein activation, enabling robust Wnt signaling modulation in research. Its high potency, validated specificity, and performance in ex vivo and in vivo models make IWP-L6 a leading tool for developmental biology and tissue regeneration studies.
Rotenone: Mitochondrial Complex I Inhibitor for Precision Mo
2026-07-21
Rotenone is the gold-standard mitochondrial Complex I inhibitor, enabling reproducible cellular and in vivo models of neurodegeneration and oxidative stress. This article delivers actionable workflow enhancements, troubleshooting strategies, and data-driven insights to maximize the reliability and interpretability of Rotenone-based experiments.
AMPK Modulates M1 Macrophage Polarization in Obesity-Related
2026-07-21
This study elucidates how AMPK activation dampens airway inflammation in obesity-related asthma by regulating M1 macrophage polarization via the JAK2/STAT3 pathway. The findings provide mechanistic insight into metabolic inflammation and suggest AMPK as a promising target for further metabolic disease research.
Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi
2026-07-20
Anlotinib hydrochloride redefines angiogenesis research as a potent, selective multi-target tyrosine kinase inhibitor, enabling robust endothelial cell migration and tube formation assays. Integrating evidence-based protocols and practical troubleshooting, this guide empowers cancer research teams to achieve reproducible, interpretable results in anti-angiogenic studies.
Lumiracoxib: Selective COX-2 Inhibitor for Muscle Injury Mod
2026-07-20
Lumiracoxib enables researchers to dissect COX-2 pathway roles in tissue regeneration, offering unmatched selectivity and robust assay performance. This guide delivers workflow strategies, troubleshooting insights, and actionable protocol parameters for reproducible inflammation studies with APExBIO’s Lumiracoxib.
nor-NOHA Acetate: Applied Arginase Inhibition in Cancer Work
2026-07-19
nor-NOHA (acetate) unlocks precision arginase inhibition for dissecting arginine metabolism in cancer and endothelial models. This guide translates recent reference breakthroughs into actionable workflow protocols, troubleshooting strategies, and advanced use-cases that maximize research impact.
DiscoveryProbe Bioactive Compound Library Plus in Ligand Scr
2026-07-18
The DiscoveryProbe™ Bioactive Compound Library Plus accelerates high-throughput pathway analysis and ligand discovery in bacterial sensor research. Its 5072 compound diversity, rigorous QC, and pre-dissolved 10 mM DMSO format streamline thermal shift and functional assays, bridging mechanistic insight with translational potential.
Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit
2026-07-17
The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit enables high-resolution separation of small proteins and peptides (1–10 kDa) that are not efficiently resolved by conventional Tris-glycine SDS-PAGE systems. It is intended for research workflows focused on low molecular weight protein and peptide analysis and should not be used for diagnostic, clinical, or medical applications.
nor-NOHA Acetate: Applied Arginase Inhibition in Cancer Mode
2026-07-17
nor-NOHA acetate from APExBIO enables precise, reversible arginase inhibition, driving reproducible results in cancer metabolism research. This guide details advanced workflows, troubleshooting strategies, and the latest insights linking arginine metabolism to immune escape mechanisms.
Dual Inhibition of BRD4 and RAC1 Disrupts Breast Cancer Epig
2026-07-16
This study uncovers a novel therapeutic strategy in breast cancer by co-targeting BET bromodomain BRD4 and RAC1, resulting in suppressed tumor growth and stemness via epigenetic circuit disruption. The findings highlight the mechanistic impact of disrupting the c-MYC-G9a-FTH1 axis and downregulating HDAC1, offering new directions for cancer epigenetics research.
462 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page